NanoViricides
NNVC
#10544
Rank
โ‚น3.28 B
Marketcap
โ‚น128.67
Share price
3.01%
Change (1 day)
-13.61%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น0.11 Billion

According to NanoViricides's latest financial reports the company's total liabilities are โ‚น0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30โ‚น0.16 B412.08%
2022-06-30โ‚น32.59 M24.83%
2021-06-30โ‚น26.11 M-84.01%
2020-06-30โ‚น0.16 B-16.81%
2019-06-30โ‚น0.19 B225.28%
2018-06-30โ‚น60.36 M-86.02%
2017-06-30โ‚น0.43 B-52.92%
2016-06-30โ‚น0.91 B16.28%
2015-06-30โ‚น0.78 B-35.83%
2014-06-30โ‚น1.22 B145.82%
2013-06-30โ‚น0.49 B406.03%
2012-06-30โ‚น98.78 M277.29%
2011-06-30โ‚น26.18 M-77.19%
2010-06-30โ‚น0.11 B365.2%
2009-06-30โ‚น24.67 M-43.88%
2008-06-30โ‚น43.97 M27.65%
2007-06-30โ‚น34.44 M-50.15%
2006-06-30โ‚น69.09 M2306.5%
2005-06-30โ‚น2.87 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
โ‚น3.533 T 3,159,164.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น8.247 T 7,375,101.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.139 T 5,489,687.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น6.644 T 5,941,523.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น107.65 B 96,167.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น95.05 B 84,902.35%๐Ÿ‡บ๐Ÿ‡ธ USA